For: | Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 2005; 11(12): 1843-1847 [PMID: 15793878 DOI: 10.3748/wjg.v11.i12.1843] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i12/1843.htm |
Number | Citing Articles |
1 |
G. GERSTNER, M. L. DAMIANO, A. TOM, C. WORMAN, W. SCHULTZ, M. RECHT, A. T. STOPECK. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia 2009; 15(2): 559 doi: 10.1111/j.1365-2516.2008.01963.x
|
2 |
Michael T. Yin, Michelle A. Kendall, Xingye Wu, Katherine Tassiopoulos, Marc Hochberg, Jeannie S. Huang, Marshall J. Glesby, Hector Bolivar, Grace A. McComsey. Fractures after antiretroviral initiation. AIDS 2012; 26(17): 2175 doi: 10.1097/QAD.0b013e328359a8ca
|
3 |
Sangheun Lee, Jun Yong Park, Kijun Song, Do Young Kim, Beom Kyung Kim, Seung Up Kim, Hye Jin Ku, Kwang-Hyub Han, Sang Hoon Ahn. Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B. Gut and Liver 2015; 9(6): 776 doi: 10.5009/gnl14297
|
4 |
Germán López-Larramona, Alfredo J Lucendo, Sonia González-Castillo, José M Tenias. Hepatic osteodystrophy: An important matter for consideration in chronic liver disease. World Journal of Hepatology 2011; 3(12): 300-307 doi: 10.4254/wjh.v3.i12.300
|
5 |
Eric Bonnet, Jean-Bernard Ruidavets, Anne Genoux, Laurence Mabile, Florian Busato, Martine Obadia, François Prévoteau, Bruno Marchou, Patrice Massip, Fabrice Marion-Latard, Cyrille Delpierre, Jacques Bernard, Bertrand Perret. Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study. BMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-293
|
6 |
Jennifer C. Lai, Dolores M. Shoback, Jacob Zipperstein, Blanca Lizaola, Samuel Tseng, Norah A. Terrault. Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C. Digestive Diseases and Sciences 2015; 60(6): 1813 doi: 10.1007/s10620-014-3507-6
|
7 |
Mohammadreza Bordbar, Sara Olyaeinezhad, Forough Saki, Sezaneh Haghpanah. Prevalence of Low Bone Mass in Patients with Hemophilia and Its Related Ractors in Southern Iran. Journal of Comprehensive Pediatrics 2020; 11(4) doi: 10.5812/compreped.97291
|
8 |
Bruce A. Luxon. Bone Disorders in Chronic Liver Diseases. Current Gastroenterology Reports 2011; 13(1): 40 doi: 10.1007/s11894-010-0166-4
|
9 |
X.L. Bai, T.B. Liang, L.H. Wu, D.L. Li, L. Geng, W.L. Wang, Y. Shen, M. Zhang, S.S. Zheng. Elevation of Intact Parathyroid Hormone Level Is a Risk Factor for Low Bone Mineral Density in Pretransplant Patients With Liver Diseases. Transplantation Proceedings 2007; 39(10): 3182 doi: 10.1016/j.transproceed.2007.06.093
|
10 |
Ali Gur, Bünyamin Dikici, Kemal Nas, Mehmet Bosnak, Kenan Haspolat, Aysegul Jale Sarac. Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?. BMC Gastroenterology 2005; 5(1) doi: 10.1186/1471-230X-5-30
|
11 |
|
12 |
Anindita Banerjee, Shreyasi Athalye, Naveen Khargekar, Poonam Shingade, Manisha Madkaikar. Chronic Hepatitis B and Related Liver Diseases Are Associated with Reduced 25-Hydroxy-Vitamin D Levels: A Systematic Review and Meta-Analysis. Biomedicines 2023; 11(1): 135 doi: 10.3390/biomedicines11010135
|
13 |
Núria Guañabens, Albert Parés. Liver and bone. Archives of Biochemistry and Biophysics 2010; 503(1): 84 doi: 10.1016/j.abb.2010.05.030
|
14 |
Scott Fung, Peter Kwan, Milotka Fabri, Andrzej Horban, Mijomir Pelemis, Hie-Won Hann, Selim Gurel, Florin A. Caruntu, John F. Flaherty, Benedetta Massetto, Phillip Dinh, Amoreena Corsa, G. Mani Subramanian, John G. McHutchison, Petr Husa, Edward Gane. Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B. Gastroenterology 2014; 146(4): 980 doi: 10.1053/j.gastro.2013.12.028
|
15 |
José M. Olmos-Martínez, José L. Hernández, Emilio Fábrega, José M. Olmos, Javier Crespo, Jesús González-Macías. Bone mineral density and trabecular bone score in treatment-naïve patients with non-cirrhotic hepatitis C virus infection. Archives of Osteoporosis 2020; 15(1) doi: 10.1007/s11657-020-00752-1
|
16 |
Panagiotis Kafas, Ilias Andreopoul, Georgios Kafas. Is the Success of Implant Surgery Influenced by Hepatitis B Condition? A Case Report. Journal of Medical Sciences 2007; 7(6): 1065 doi: 10.3923/jms.2007.1065.1067
|
17 |
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, Joseph M Pappachan. Metabolic complications of hepatitis C virus infection. World Journal of Gastroenterology 2021; 27(13): 1267-1282 doi: 10.3748/wjg.v27.i13.1267
|
18 |
Ming-Shyan Lin, Po-Han Chen, Po-Chang Wang, Huang-Shen Lin, Tung-Jung Huang, Shih-Tai Chang, Wen-Nan Chiu, Mei-Yen Chen. Association between hepatitis C virus infection and osteoporotic fracture risk among postmenopausal women: a cross-sectional investigation in Taiwan. BMJ Open 2019; 9(1): e021990 doi: 10.1136/bmjopen-2018-021990
|
19 |
Stefano Mora, Vania Giacomet, Alessandra Viganò, Katia Maruca, Silvia Capelli, Pilar Nannini, Gian Vincenzo Zuccotti. Areal Bone Mineral Density in Pediatric Patients with Chronic Hepatitis B or Chronic Hepatitis C. Calcified Tissue International 2014; 95(3): 218 doi: 10.1007/s00223-014-9884-1
|
20 |
Meital Gal-Tanamy, Larisa Bachmetov, Amiram Ravid, Ruth Koren, Arie Erman, Ran Tur-Kaspa, Romy Zemel. Vitamin D: An innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 2011; 54(5): 1570 doi: 10.1002/hep.24575
|
21 |
Astushi Nakamura, Tsubasa Yoshimura, Shunsuke Nagata, Manami Deguchi, Yuei Hosokawa, Go Someya, Takeshi Ichikawa, Keiji Okuyama, Yosihiro Yosioka, Hitoshi Asakura, Kenji Ogawa. Bone mass reductions in patients with chronic liver disease: the significance of bone mineral density measurements of vertebral bones using abdominal computed tomography. Kanzo 2019; 60(11): 414 doi: 10.2957/kanzo.60.414
|
22 |
Leon Fisher, Alexander Fisher. Vitamin D and Parathyroid Hormone in Outpatients With Noncholestatic Chronic Liver Disease. Clinical Gastroenterology and Hepatology 2007; 5(4): 513 doi: 10.1016/j.cgh.2006.10.015
|
23 |
Liliana Montella, Raffaele Addeo, Giovannella Palmieri, Michele Caraglia, Gregorio Cennamo, Bruno Vincenzi, Rosario Guarrasi, Rosanna Mamone, Vincenzo Faiola, Nicola Frega, Elena Capasso, Luigi Maiorino, Davide Leopardo, Carmine Pizza, Vincenzo Montesarchio, Salvatore Del Prete. Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series. Cancer Chemotherapy and Pharmacology 2010; 65(6): 1137 doi: 10.1007/s00280-009-1122-6
|
24 |
Ahmad Amanzada, Armin D. Goralczyk, Federico Moriconi, David H. van Thiel, Giuliano Ramadori, Sabine Mihm. Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection. Journal of Medical Virology 2013; 85(9): 1534 doi: 10.1002/jmv.23632
|
25 |
Connie Tien, Jason J. Xu, Linda S. Chan, Mimi Chang, Carolina Lim, Sue Lee, Brian Huh, Shuntaro Shinada, Ho S. Bae, Tse-Ling Fong. Long-Term Treatment with Tenofovir in Asian-American Chronic Hepatitis B Patients Is Associated with Abnormal Renal Phosphate Handling. Digestive Diseases and Sciences 2015; 60(2): 566 doi: 10.1007/s10620-014-3363-4
|
26 |
Alessandro Mantovani, Marco Dauriz, Davide Gatti, Ombretta Viapiana, Giacomo Zoppini, Giuseppe Lippi, Christopher D. Byrne, Fabrice Bonnet, Enzo Bonora, Giovanni Targher. Systematic review with meta‐analysis: non‐alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density. Alimentary Pharmacology & Therapeutics 2019; 49(4): 375 doi: 10.1111/apt.15087
|
27 |
Eiichi Ogawa, Dae Won Jun, Hidenori Toyoda, Yao‐Chun Hsu, Eileen L. Yoon, Sang Bong Ahn, Ming‐Lun Yeh, Son Do, Huy N. Trinh, Hirokazu Takahashi, Masaru Enomoto, Norifumi Kawada, Satoshi Yasuda, Cheng‐Hao Tseng, Keigo Kawashima, Han Ah Lee, Kaori Inoue, Hiroaki Haga, Ai‐Thien Do, Mayumi Maeda, Joseph H. Hoang, Ramsey Cheung, Yoshiyuki Ueno, Yuichiro Eguchi, Norihiro Furusyo, Ming‐Lung Yu, Yasuhito Tanaka, Mindie H. Nguyen. Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study. Alimentary Pharmacology & Therapeutics 2024; 59(2): 239 doi: 10.1111/apt.17785
|
28 |
Olga Katsarou, Evangelos Terpos, Pantelis Chatzismalis, Stefanos Provelengios, Theophanis Adraktas, Dimitrios Hadjidakis, Anna Kouramba, Anastasia Karafoulidou. Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection. Annals of Hematology 2010; 89(1): 67 doi: 10.1007/s00277-009-0759-x
|
29 |
Panagiotis V. Katsaounis, Emilia S. Hadjiyannis, Teressa Skaltsi, Vassiliki A. Anargyrou, Alexandra A. Alexopoulou, Spyridon P. Dourakis, John S. Koskinas. Bone disease in patients with cirrhosis of different etiology and severity; are Klotho protein and osteoprotegerin potential biomarkers?. Scandinavian Journal of Gastroenterology 2023; 58(2): 185 doi: 10.1080/00365521.2022.2114813
|
30 |
Tugrul Purnak, Yavuz Beyazit, Ersan Ozaslan, Cumali Efe, Merve Hayretci. The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease. Wiener klinische Wochenschrift 2012; 124(15-16): 526 doi: 10.1007/s00508-012-0211-4
|
31 |
P. Guggenbuhl, G. Chalès. Os et foie. EMC - Hépatologie 2013; 8(2): 1 doi: 10.1016/S1155-1976(12)59777-9
|
32 |
Astrid E. Pulles, Simon C. Mastbergen, Roger E.G. Schutgens, Floris P.J.G. Lafeber, Lize F.D. van Vulpen. Pathophysiology of hemophilic arthropathy and potential targets for therapy. Pharmacological Research 2017; 115: 192 doi: 10.1016/j.phrs.2016.11.032
|
33 |
M. T. Yin, A. RoyChoudhury, K. Nishiyama, T. Lang, J. Shah, S. Olender, D. C. Ferris, C. Zeana, A. Sharma, B. Zingman, M. Bucovsky, I. Colon, E. Shane. Bone density and microarchitecture in hepatitis C and HIV-coinfected postmenopausal minority women. Osteoporosis International 2018; 29(4): 871 doi: 10.1007/s00198-017-4354-z
|
34 |
Andrija Jurina, Valentina Delimar, Zlatko Giljević, Tajana Filipec Kanižaj, Andro Matković, Dinko Vidović, Nikolina Jurjević, Vinko Vidjak, Željko Duić, Mario Ćuk, Mladen Japjec, Tomislav Dujmović, Andrea Radeljak, Mirjana Marjana Kardum Paro, Marijana Vučić-Lovrenčić, Mario Starešinić. Fragility spinal fractures among cirrhotic liver transplant candidates in Croatia. Injury 2024; 55(2): 111171 doi: 10.1016/j.injury.2023.111171
|
35 |
Jerzy Konstantynowicz, Dariusz M. Lebensztejn, Elzbieta Skiba, Maria E. Sobaniec-Lotowska, Pawel Abramowicz, Janina Piotrowska-Jastrzebska, Maciej Kaczmarski. Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children. Journal of Bone and Mineral Metabolism 2011; 29(3): 315 doi: 10.1007/s00774-010-0219-7
|
36 |
Christopher J. Danford, Hirsh D. Trivedi, Alan Bonder. Bone Health in Patients With Liver Diseases. Journal of Clinical Densitometry 2020; 23(2): 212 doi: 10.1016/j.jocd.2019.01.004
|
37 |
Jae Young Jang, Raymond T. Chung. New treatments for chronic hepatitis C. The Korean Journal of Hepatology 2010; 16(3): 263 doi: 10.3350/kjhep.2010.16.3.263
|
38 |
Myong Ki Baeg, Seung Kew Yoon, Sun-Hye Ko, Kyung-Do Han, Hye Jin Choi, Si Hyun Bae, Jong Young Choi, Myung-Gyu Choi. Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008–2010 Korea National Health and Nutrition Examination Surveys. Hepatology International 2016; 10(3): 470 doi: 10.1007/s12072-015-9672-7
|
39 |
Wen-Hung Huang, Mei-Ching Yu, Jeng-Yi Huang, Ping-Chin Lai, Birke Bartosch. Impact of Hepatitis C Virus Infection on Bone Mineral Density in Renal Transplant Recipients. PLoS ONE 2013; 8(5): e63263 doi: 10.1371/journal.pone.0063263
|
40 |
Anirban Mukhopadhyay, Ujjwal Maulik, Wenzhe Ho. Network-Based Study Reveals Potential Infection Pathways of Hepatitis-C Leading to Various Diseases. PLoS ONE 2014; 9(4): e94029 doi: 10.1371/journal.pone.0094029
|
41 |
A. Mahmoudi, N. Sellier, J. Reboul-Marty, G. Chalès, Y. Lalatonne, V. Bourcier, V. Grando, N. Barget, M. Beaugrand, J.-C. Trinchet, N. Ganne-Carrié. Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study. Clinics and Research in Hepatology and Gastroenterology 2011; 35(11): 731 doi: 10.1016/j.clinre.2011.07.009
|
42 |
Todd T. Brown, Michael T. Yin. Marcus and Feldman's Osteoporosis. 2021; : 1217 doi: 10.1016/B978-0-12-813073-5.00049-6
|
43 |
Anne Liu, An Le, Jian Zhang, Chris Wong, Clifford Wong, Linda Henry, Mindie H. Nguyen. Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000–2015. Clinical and Translational Gastroenterology 2018; 9(3): e141 doi: 10.1038/s41424-018-0007-6
|
44 |
Ann-Brit Eg Hansen, Lars Haukali Omland, Henrik Krarup, Niels Obel. Fracture risk in hepatitis C virus infected persons: Results from the DANVIR cohort study. Journal of Hepatology 2014; 61(1): 15 doi: 10.1016/j.jhep.2014.03.007
|
45 |
Tatiana Bering, Kiara G.D. Diniz, Marta Paula P. Coelho, Diego A. Vieira, Maria Marta S. Soares, Adriana M. Kakehasi, Maria Isabel T.D. Correia, Rosângela Teixeira, Dulciene M.M. Queiroz, Gifone A. Rocha, Luciana D. Silva. Association between pre‐sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C. Journal of Cachexia, Sarcopenia and Muscle 2018; 9(2): 255 doi: 10.1002/jcsm.12269
|
46 |
Mahmoud M. Sobh, Mohamed Abdalbary, Sherouk Elnagar, Eman Nagy, Nehal Elshabrawy, Mostafa Abdelsalam, Kamyar Asadipooya, Amr El-Husseini. Secondary Osteoporosis and Metabolic Bone Diseases. Journal of Clinical Medicine 2022; 11(9): 2382 doi: 10.3390/jcm11092382
|
47 |
Subhra Karmakar, Sangita Majumdar, Anasuya Maiti, Monalisa Choudhury, Aniruddha Ghosh, Asankur S. Das, Chandan Mitra. Protective Role of Black Tea Extract against Nonalcoholic Steatohepatitis-Induced Skeletal Dysfunction. Journal of Osteoporosis 2011; 2011: 1 doi: 10.4061/2011/426863
|
48 |
Luciana G. S. Orsini, Marcelo M. Pinheiro, Charlles H. M. Castro, Antônio E. B. Silva, Vera L. Szejnfeld, Luc Malaval. Bone Mineral Density Measurements, Bone Markers and Serum Vitamin D Concentrations in Men with Chronic Non-Cirrhotic Untreated Hepatitis C. PLoS ONE 2013; 8(11): e81652 doi: 10.1371/journal.pone.0081652
|
49 |
Kanjaksha Ghosh, Shrimati Shetty. Bone health in persons with haemophilia: a review. European Journal of Haematology 2012; 89(2): 95 doi: 10.1111/j.1600-0609.2012.01803.x
|
50 |
Aida Elleuch, Lassaad Chtourou, Khansa Chaabouni, Khalil Yaich, Manel Naifar, Hela Fourati, Ali Amouri, Sofien Baklouti, Nabil Tahri, Fatma Ayadi. Ostéodystrophie et marqueurs de remodelage osseux au cours des hépatopathies virales chroniques compensées. Nutrition Clinique et Métabolisme 2020; 34(2): 149 doi: 10.1016/j.nupar.2019.10.002
|
51 |
Chien-Hua Chen, Cheng-Li Lin, Chia-Hung Kao. Association Between Chronic Hepatitis B Virus Infection and Risk of Osteoporosis. Medicine 2015; 94(50): e2276 doi: 10.1097/MD.0000000000002276
|
52 |
Salvatore Petta, Donatella Ferraro, Calogero Cammà, Daniela Cabibi, Antonietta Di Cristina, Vito Di Marco, Rosa Di Stefano, Stefania Grimaudo, Alessandra Mazzola, Massimo Levrero, Concetta Scazzone, Antonio Craxì. Vitamin D Levels and Il28B Polymorphisms are Related to Rapid Virological Response to Standard of Care in Genotype 1 Chronic Hepatitis C. Antiviral Therapy 2012; 17(5): 823 doi: 10.3851/IMP2100
|
53 |
Olivia McKenna, Catherine Blake. Management of hepatitis C: the potential benefits of exercise. Physical Therapy Reviews 2007; 12(4): 271 doi: 10.1179/108331907X223065
|
54 |
Diala El-Maouche, Shruti H. Mehta, Catherine Sutcliffe, Yvonne Higgins, Michael S. Torbenson, Richard D. Moore, David L. Thomas, Mark S. Sulkowski, Todd T. Brown. Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. Journal of Hepatology 2011; 55(4): 770 doi: 10.1016/j.jhep.2011.01.035
|
55 |
Agostino Gaudio, Piera Pennisi, Francesco Muratore, Gaetano Bertino, Annalisa Ardiri, Ivana Pulvirenti, Giovanni Tringali, Carmelo Erio Fiore. Reduction of volumetric bone mineral density in postmenopausal women with hepatitis C virus-correlated chronic liver disease: A peripheral quantitative computed tomography (pQCT) study. European Journal of Internal Medicine 2012; 23(7): 656 doi: 10.1016/j.ejim.2012.05.011
|
56 |
Trevor A. Crowell, Kelly A. Gebo, Ashwin Balagopal, John A. Fleishman, Allison L. Agwu, Stephen A. Berry. Impact of Hepatitis Coinfection on Hospitalization Rates and Causes in a Multicenter Cohort of Persons Living With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 2014; 65(4): 429 doi: 10.1097/QAI.0000000000000059
|
57 |
Kavinderjit S. Nanda, Elizabeth J. Ryan, Barbara F. Murray, Jennifer J. Brady, Malachi J. McKenna, Niamh Nolan, Cliona O'Farrelly, John E. Hegarty. Effect of Chronic Hepatitis C Virus Infection on Bone Disease in Postmenopausal Women. Clinical Gastroenterology and Hepatology 2009; 7(8): 894 doi: 10.1016/j.cgh.2009.01.011
|
58 |
T. A. WALLNY, D. T. SCHOLZ, J. OLDENBURG, C. NICOLAY, S. EZZIDDIN, P. H. PENNEKAMP, B. STOFFEL‐WAGNER, C. N. KRAFT. Osteoporosis in haemophilia – an underestimated comorbidity?. Haemophilia 2007; 13(1): 79 doi: 10.1111/j.1365-2516.2006.01405.x
|
59 |
Michael T. Yin, Todd T. Brown. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 2018; : 474 doi: 10.1002/9781119266594.ch60
|
60 |
Ping Wang, Xue-Song Gao, Yao-Nan Zhang, Xue-Fei Duan. Progress in research of non-cirrhotic chronic viral hepatitis with osteoporosis. World Chinese Journal of Digestology 2022; 30(11): 491 doi: 10.11569/wcjd.v30.i11.491
|
61 |
Juan Kong, Yang Ding, Cong Zhang, Yu Fu, Jie Du, Cheng Lu, Xiaoguang Dou, Yunzi Chen, Yan Chun Li, Qun Zhao. Severe Vitamin D-Deficiency and Increased Bone Turnover in Patients with Hepatitis B from Northeastern China. Endocrine Research 2013; 38(4): 215 doi: 10.3109/07435800.2013.768266
|
62 |
E. Cholongitas, E. Theocharidou, J. Goulis, E. Tsochatzis, E. Akriviadis, A. K. Burroughs. Review article: the extra‐skeletal effects of vitamin D in chronic hepatitis C infection. Alimentary Pharmacology & Therapeutics 2012; 35(6): 634 doi: 10.1111/j.1365-2036.2012.05000.x
|
63 |
Upkar S. Gill, Alexandra Zissimopoulos, Safa Al-Shamma, Katherine Burke, Mark J. W. McPhail, David A. Barr, Yiannis N. Kallis, Richard T. C. Marley, Paul Kooner, Graham R. Foster, Patrick T. F. Kennedy. Assessment of Bone Mineral Density in Tenofovir-Treated Patients With Chronic Hepatitis B: Can the Fracture Risk Assessment Tool Identify Those at Greatest Risk?. Journal of Infectious Diseases 2015; 211(3): 374 doi: 10.1093/infdis/jiu471
|
64 |
Chisato Saeki, Mitsuru Saito, Akihito Tsubota. Association of chronic liver disease with bone diseases and muscle weakness. Journal of Bone and Mineral Metabolism 2024; 42(4): 399 doi: 10.1007/s00774-023-01488-x
|
65 |
Dana D. Byrne, Craig W. Newcomb, Dena M. Carbonari, Melissa S. Nezamzadeh, Kimberly B.F. Leidl, Maximilian Herlim, Yu-Xiao Yang, Sean Hennessy, Jay R. Kostman, Mary B. Leonard, A. Russell Localio, Vincent Lo Re. Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection. Journal of Hepatology 2014; 61(2): 210 doi: 10.1016/j.jhep.2014.04.001
|
66 |
Michael T Yin, Qiuhu Shi, Donald R Hoover, Kathryn Anastos, Anjali Sharma, Mary Young, Alexandra Levine, Mardge H Cohen, Elizabeth Shane, Elizabeth T Golub, Phyllis C Tien. Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study. AIDS 2010; 24(17): 2679 doi: 10.1097/QAD.0b013e32833f6294
|
67 |
Anitha Yadav, Elizabeth J. Carey. Osteoporosis in Chronic Liver Disease. Nutrition in Clinical Practice 2013; 28(1): 52 doi: 10.1177/0884533612470145
|
68 |
M. Guarino, I. Loperto, S. Camera, V. Cossiga, C. Di Somma, A. Colao, N. Caporaso, F. Morisco. Osteoporosis across chronic liver disease. Osteoporosis International 2016; 27(6): 1967 doi: 10.1007/s00198-016-3512-z
|
69 |
Arthur Belle, Emmanuel Gizard, Guillaume Conroy, Anthony Lopez, Magali Bouvier‐Alias, Stéphanie Rouanet, Laurent Peyrin‐Biroulet, Jean‐Michel Pawlotsky, Jean‐Pierre Bronowicki. 25‐OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV‐infected patients. United European Gastroenterology Journal 2017; 5(1): 69 doi: 10.1177/2050640616640157
|
70 |
Ahmed Megahed, Nanees Salem, Abeer Fathy, Tarik Barakat, Mona Abd El Latif Alsayed, Suzy Abd El Mabood, Khaled R. Zalata, Ahmed F. Abdalla. Pegylated interferon α/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infection. World Journal of Pediatrics 2017; 13(4): 346 doi: 10.1007/s12519-017-0013-x
|
71 |
Chien-Hua Chen, Cheng-Li Lin, Chia-Hung Kao. Relation Between Hepatitis C Virus Exposure and Risk of Osteoporosis. Medicine 2015; 94(47): e2086 doi: 10.1097/MD.0000000000002086
|
72 |
R. Pelazas González, E. González Reimers, R. Alemán Valls, E. García-Valdecasas, M.J. de La Vega Prieto, M.A. Gómez Rodríguez, J. López Prieto, F. Santolaria fernández. Osteopatía en el paciente afecto de infección por virus C. Revista Española de Enfermedades Metabólicas Óseas 2009; 18(1): 15 doi: 10.1016/S1132-8460(09)70766-4
|
73 |
Michael T. Yin, Todd T. Brown. HIV and Bone Complications: Understudied Populations and New Management Strategies. Current HIV/AIDS Reports 2016; 13(6): 349 doi: 10.1007/s11904-016-0341-9
|
74 |
Yan Yang, Jing Zeng, Tingting Zhang, Jinjing Wang, Xiaojing Fan, Qiaomin Wang, Xuan Wang, Zhengrong Qi, Yi Fang. Association between resolved hepatitis B virus infection and femoral and spinal bone mineral density in American adults: a cross-sectional study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1237618
|
75 |
Inaam A. Nakchbandi, Schalk W. van der Merwe. Current understanding of osteoporosis associated with liver disease. Nature Reviews Gastroenterology & Hepatology 2009; 6(11): 660 doi: 10.1038/nrgastro.2009.166
|
76 |
Emilio González-Reimers, Javier López-Prieto, Ricardo Pelazas-González, M.Remedios Alemán-Valls, María José de la Vega-Prieto, Carlos Jorge-Ripper, M. Carmen Durán-Castellón, F Santolaria-Fernández. Serum Sclerostin in Hepatitis C Virus Infected Patients. Journal of Bone Metabolism 2014; 21(1): 69 doi: 10.11005/jbm.2014.21.1.69
|
77 |
Naim M Maalouf, Song Zhang, Henning Drechsler, Geri R Brown, Pablo Tebas, Roger Bedimo. Hepatitis C Co-infection and Severity of Liver Disease as Risk Factors for Osteoporotic Fractures Among HIV-Infected Patients. Journal of Bone and Mineral Research 2013; 28(12): 2577 doi: 10.1002/jbmr.1988
|
78 |
Gabriela Handzlik-Orlik, Michał Holecki, Krzysztof Wilczyński, Jan Duława. Osteoporosis in liver disease: pathogenesis and management. Therapeutic Advances in Endocrinology and Metabolism 2016; 7(3): 128 doi: 10.1177/2042018816641351
|
79 |
Nilüfer İrem Tunçer, Ayça Arman-Özçırpıcı, Bahar Füsun Oduncuoğlu, Alpdoğan Kantarcı. Osseous outgrowth on the buccal maxilla associated with piezosurgery-assisted en-masse retraction: A case series. The Korean Journal of Orthodontics 2018; 48(1): 57 doi: 10.4041/kjod.2018.48.1.57
|
80 |
Roger Bedimo, Minhee Kang, Pablo Tebas, Edgar T. Overton, Kimberly Hollabaugh, Grace McComsey, Debika Bhattacharya, Christopher Evans, Todd T. Brown, Babafemi Taiwo. Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients. AIDS Research and Human Retroviruses 2016; 32(4): 325 doi: 10.1089/aid.2015.0204
|
81 |
Hae Jeong, Dong Kim. Bone Diseases in Patients with Chronic Liver Disease. International Journal of Molecular Sciences 2019; 20(17): 4270 doi: 10.3390/ijms20174270
|
82 |
Rein Jan Piso, Madeleine Rothen, Jean Pierre Rothen, Matthias Stahl, Christoph Fux. Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients. BMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-577
|
83 |
E. Redondo-Cerezo, F. Casado-Caballero, J. L. Martin-Rodriguez, J. Hernandez-Quero, F. Escobar-Jimenez, J. L. Gonzalez-Calvin. Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin. Osteoporosis International 2014; 25(6): 1709 doi: 10.1007/s00198-014-2663-z
|
84 |
Mahmoud Aboelneen Khattab. Targeting host factors: A novel rationale for the management of hepatitis C virus. World Journal of Gastroenterology 2009; 15(28): 3472-3479 doi: 10.3748/wjg.15.3472
|
85 |
Ulrich Christian Bang, Thomas Benfield, Flemming Bendtsen, Lars Hyldstrup, Jens–Erik Beck Jensen. The Risk of Fractures Among Patients With Cirrhosis or Chronic Pancreatitis. Clinical Gastroenterology and Hepatology 2014; 12(2): 320 doi: 10.1016/j.cgh.2013.04.031
|
86 |
Sylvie Lawson-Ayayi, Charles Cazanave, Alphonse Kpozehouen, Nicole Barthe, Nadia Mehsen, Mojgan Hessamfar, Michel Dupon, François Dabis, Didier Neau. Chronic Viral Hepatitis Is Associated With Low Bone Mineral Density in HIV-Infected Patients, ANRS CO 3 Aquitaine Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes 2013; 62(4): 430 doi: 10.1097/QAI.0b013e3182845d88
|
87 |
Hanaa H. Eldash, Zeze Th. Atwa, Mohammad A. Saad. Vitamin D deficiency and osteoporosis in hemophilic children. Blood Coagulation & Fibrinolysis 2017; 28(1): 14 doi: 10.1097/MBC.0000000000000519
|
88 |
Roger J Bedimo, Beverley Adams-Huet, John Poindexter, Geri Brown, Irfan Farukhi, Rosinda Castanon, Diana Turner, Teresa Moore, Pablo Tebas, Naim M Maalouf. The Differential Effects of Human Immunodeficiency Virus and Hepatitis C Virus on Bone Microarchitecture and Fracture Risk. Clinical Infectious Diseases 2018; 66(9): 1442 doi: 10.1093/cid/cix1011
|
89 |
Andrea D Branch, Minhee Kang, Kimberly Hollabaugh, Christina M Wyatt, Raymond T Chung, Marshall J Glesby. In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use. The American Journal of Clinical Nutrition 2013; 98(2): 423 doi: 10.3945/ajcn.112.048785
|
90 |
Yue-Si Zhong, Nan Lin, Mei-Hai Deng, Fu-Cheng Zhang, Zhao-Feng Tang, Rui-Yun Xu. Deficient Proliferation of Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Chronic Hepatitis B Viral Infections and Cirrhosis of the Liver. Digestive Diseases and Sciences 2010; 55(2): 438 doi: 10.1007/s10620-009-0733-4
|
91 |
E. Carlos Rodríguez-Merchán, Víctor Jiménez-Yuste. Advances in Hemophilia Treatment. 2022; : 1 doi: 10.1007/978-3-030-93990-8_1
|
92 |
Pasquale Mansueto, Antonio Carroccio, Aurelio Seidita, Gaetana Di Fede, Antonio Craxì. Osteodystrophy in chronic liver diseases. Internal and Emergency Medicine 2013; 8(5): 377 doi: 10.1007/s11739-012-0753-5
|
93 |
Vijay Kumar, Amrita Chawla, Amandeep Kaur. Multiple Idiopathic Cervical Root Resorptions in Patients with Hepatitis B Virus Infection. Journal of Endodontics 2018; 44(10): 1575 doi: 10.1016/j.joen.2018.06.017
|
94 |
Núria Guañabens, Albert Parés. Osteoporosis in chronic liver disease. Liver International 2018; 38(5): 776 doi: 10.1111/liv.13730
|
95 |
Wang-Sheng Ko, Fang-Ping Shen, Chia-Ju Shih, Ya-Ling Chiou. The 25(OH)Vitamin D Status Affected the Effectiveness of Oligo Fucoidan in Patients with Chronic Hepatitis B Virus Infection with Immune Tolerance Phase. Nutrients 2020; 12(2): 321 doi: 10.3390/nu12020321
|
96 |
Christian Markus Lange, Jörg Bojunga, Elizabeth Ramos-Lopez, Michael von Wagner, Angela Hassler, Johannes Vermehren, Eva Herrmann, Klaus Badenhoop, Stefan Zeuzem, Christoph Sarrazin. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. Journal of Hepatology 2011; 54(5): 887 doi: 10.1016/j.jhep.2010.08.036
|
97 |
W. P. Hofmann, B. Kronenberger, J. Bojunga, B. Stamm, E. Herrmann, A. Bücker, U. Mihm, M. Von Wagner, S. Zeuzem, C. Sarrazin. Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon α and ribavirin therapy. Journal of Viral Hepatitis 2008; 15(11): 790 doi: 10.1111/j.1365-2893.2008.01038.x
|
98 |
Huan V. Dong, Yamnia I. Cortés, Stephanie Shiau, Michael T. Yin. Osteoporosis and fractures in HIV/hepatitis C virus coinfection. AIDS 2014; 28(14): 2119 doi: 10.1097/QAD.0000000000000363
|
99 |
Young Joo Yang, Dong Joon Kim. An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia. International Journal of Molecular Sciences 2021; 22(5): 2604 doi: 10.3390/ijms22052604
|
100 |
N. Lim, S. Jackson, C. Engler, J.R. Lake. The Impact of Tenofovir Disoproxil Fumarate on Reduced Bone Mineral Density and Fractures in Liver Transplant Recipients. Transplantation Proceedings 2021; 53(1): 215 doi: 10.1016/j.transproceed.2020.09.009
|
101 |
Ricardo Pelazas-González, Emilio González-Reimers, María Remedios Alemán-Valls, Francisco Santolaria-Fernández, Javier López-Prieto, Antonieta González-Díaz, Juan Luis Gómez-Sirvent, María José de la Vega-Prieto. Bone alterations in hepatitis C virus infected patients. European Journal of Internal Medicine 2013; 24(1): 92 doi: 10.1016/j.ejim.2012.09.007
|
102 |
D. D. Byrne, C. W. Newcomb, D. M. Carbonari, M. S. Nezamzadeh, K. B. F. Leidl, M. Herlim, Y. X. Yang, S. Hennessy, J. R. Kostman, M. B. Leonard, A. R. Localio, V. Lo Re. Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfection. Journal of Viral Hepatitis 2015; 22(11): 936 doi: 10.1111/jvh.12398
|
103 |
S. Linari, G. Montorzi, D. Bartolozzi, M. Borderi, D. Melchiorre, M. Benelli, M. Morfini. Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patients. Haemophilia 2013; 19(1): 126 doi: 10.1111/j.1365-2516.2012.02899.x
|
104 |
M. KHAWAJI, K. ÅKESSON, E. BERNTORP. Long‐term prophylaxis in severe haemophilia seems to preserve bone mineral density. Haemophilia 2009; 15(1): 261 doi: 10.1111/j.1365-2516.2008.01912.x
|
105 |
Pál Miheller, Péter L. Lakatos, Miklós Tóth. Bone Homeostasis in Intestinal Disorders. Clinical Reviews in Bone and Mineral Metabolism 2010; 8(3): 140 doi: 10.1007/s12018-010-9069-z
|
106 |
Jung-Chun Lin, Tsai-Yuan Hsieh, Chia-Chun Wu, Peng-Jen Chen, Tung-Hung Chueh, Wei-Kuo Chang, Heng-Cheng Chu. Association Between Chronic Hepatitis C Virus Infection and Bone Mineral Density. Calcified Tissue International 2012; 91(6): 423 doi: 10.1007/s00223-012-9653-y
|
107 |
Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Hoi-Yun Chan, Chi-Hang Tse, Angel Mei-Ling Chim, Angeline Oi-Shan Lo, Vincent Wai-Sun Wong. Adverse Effects of Vitamin D Deficiency on Outcomes of Patients With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology 2015; 13(4): 783 doi: 10.1016/j.cgh.2014.09.050
|
108 |
Pascal Guggenbuhl, Gérard Chalès. Os et foie. Revue du Rhumatisme Monographies 2013; 80(2): 88 doi: 10.1016/j.monrhu.2013.02.002
|
109 |
Roger Bedimo, James Cutrell, Song Zhang, Henning Drechsler, Ang Gao, Geri Brown, Irfan Farukhi, Rosinda Castanon, Pablo Tebas, Naim M. Maalouf. Mechanisms of bone disease in HIV and hepatitis C virus. AIDS 2016; 30(4): 601 doi: 10.1097/QAD.0000000000000952
|
110 |
Serdar Sahin, Sevil Sadri, Zafer Baslar, Muhlis Cem Ar. Osteoporosis in Patients With Hemophilia: Single-Center Results From a Middle-Income Country. Clinical and Applied Thrombosis/Hemostasis 2019; 25 doi: 10.1177/1076029619861689
|
111 |
C. L. Kempton, A. Antun, D. M. Antoniucci, W. Carpenter, M. Ribeiro, S. Stein, L. Slovensky, L. Elon. Bone density in haemophilia: a single institutional cross‐sectional study. Haemophilia 2014; 20(1): 121 doi: 10.1111/hae.12240
|
112 |
Roger Bedimo, Naim M. Maalouf, Vincent Lo Re. Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture. Current Opinion in HIV and AIDS 2016; 11(3): 285 doi: 10.1097/COH.0000000000000259
|